MEDISTEKOS PREKYBA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 215,190 | 235,845 | 257,201 | 217,991 | 211,685 | 157,399 | 111,560 | 101,136 |
| Profit before tax | 2,125 | 305 | 11,270 | 8,984 | -5,807 | -9,781 | -13,301 | -18,024 |
| Net profit | 2,015 | 302 | 10,703 | 8,529 | -5,807 | -9,781 | -13,301 | -18,024 |
| Equity | 85,992 | 76,294 | 86,997 | 95,526 | 76,719 | 66,938 | 53,637 | 35,613 |
| Liabilities | 18,702 | 39,708 | 51,907 | 40,637 | 4,489 | 12,452 | 4,753 | 2,295 |
| Non-current assets | 23,507 | 44,374 | 34,585 | 25,385 | 17,988 | 10,500 | 5,260 | 576 |
| Current assets | 81,069 | 71,615 | 104,170 | 110,510 | 62,112 | 67,959 | 52,825 | 37,120 |
| Total assets | 104,576 | 115,989 | 138,755 | 135,895 | 80,100 | 78,459 | 58,085 | 37,696 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,079 | 5,299 | 10,575 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -16.2% | +9.6% | +9.1% | -15.2% | -2.9% | -25.6% | -29.1% | -9.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.9% | 0.3% | 7.7% | 6.3% | -7.2% | -12.5% | -22.9% | -47.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.3% | 0.4% | 12.3% | 8.9% | -7.6% | -14.6% | -24.8% | -50.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 0.1% | 4.2% | 3.9% | -2.7% | -6.2% | -11.9% | -17.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.0% | 0.1% | 4.4% | 4.1% | -2.7% | -6.2% | -11.9% | -17.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.5 | 0.6 | 0.4 | 0.1 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 107,595 | 117,923 | 128,601 | 108,996 | 105,843 | 78,700 | 55,780 | 50,568 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDISTEKOS PREKYBA - Social security debts
The company had no debts to Sodra
MEDISTEKOS PREKYBA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDISTEKOS PREKYBA, UAB (code 125547487) is a Private Limited Liability Company engaged in non-specialised wholesale trade. In 2025, the company generated revenue of €101.1K, down 9.3% year on year and 35.8% over two years, showing a steady decline from €157.4K in 2023 to €111.6K in 2024 and then to the latest level. Profitability remained negative throughout the period and weakened further: net loss increased from €9.8K in 2023 to €13.3K in 2024 and €18.0K in 2025. The 2025 profit margin was -17.8%. The balance sheet also contracted, with total assets falling from €78.5K in 2023 to €58.1K in 2024 and €37.7K in 2025. Equity decreased to €35.6K, while liabilities were limited at €2.3K, resulting in a high equity ratio of 94.5% and debt-to-equity of 0.06. Asset turnover stood at 2.68x. Return on equity was -50.6% and return on assets -47.8%, reflecting the ongoing loss-making trend. Revenue per employee was €50.6K, while profit per employee was -€9.0K.